AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)
AAPL 193.32 +0.46 (+0.24%)MSFT 133.04 +0.1 (+0.08%)FB 181.4 +1.03 (+0.57%)ZNGA 6.2 +0.08 (+1.23%)NVDA 144.91 +0.48 (+0.33%)WBA 52.67 +0.01 (+0.02%)GOOG 1088.38 +1.34 (+0.12%)PIH 5.73 0 (0.00%)

Financial Summary ZFGN Quote Zafgen Inc.

Zafgen Inc. Quote

Zafgen Inc. (ZFGN)

1.40 0.04 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D
Symbol ZFGN
Price 1.40
Beta -0.42
Vol Avg 225.78 K
Mkt cap 45.12 M
Shares 27
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE -87.57% Strong Sell
ROA -78.31% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity 11.83% Neutral
P/E -0.51
P/B 0.22 Neutral
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 0 0 0 0 0
COGS 0 0 0 0 0
GrossProfit 0 0 0 0 0
Depreciation (included in COGS) 0 0 0 0 0
StockBasedCompe (included in COGS) 0 2 9 10 8
ResearchAndDeve 10 27 55 40 41
SalesGeneralAnd 4 8 19 18 12
OperatingIncome -14 -36 -74 -58 -53
InterestExpense 0 1 1 1 0
OtherIncome 0 0 0 1 1
IncomeBeforeTax -14 -36 -74 -58 -52
ProvisionForInc 0 0 0 0 0
NetIncome -14 -36 -74 -58 -52
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 36 58 36 32 41
ShortTermInvest 0 57 149 97 61
Cash 36 115 185 0 0
AccountReceivab 2 0 1 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 0 0 0 0
TotalCurrentAss 37 117 188 131 105
PPE 0 0 1 1 1
AccumulatedDepr 0 0 0 0 -1
NetPPE 0 0 1 1 1
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 1 0 0 0 0
TotalNonCurrent 1 0 1 1 1
TotalAssets 38 118 189 132 106
ShortTermDebt 0 1 3 4 0
AccountsPayable 2 2 7 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 1 2 4 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 0 1 2 2 0
TotalCurrentLia 3 7 17 10 7
Debt 0 6 3 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 104 0 0 0 0
TotalNonCurrent 104 6 3 0 20
TotalLiabilitie 107 13 20 10 27
CommonStock 0 0 0 0 0
AdditionalPaidI 0 210 349 359 368
RetainedEarning -69 -105 -180 -238 -290
AccumulatedOthe 0 0 0 0 0
TotalStockholde -69 104 169 122 78
TotalLiabilitie 38 118 189 132 106
Cash Flow Statement
Year 20142015201620172018
NetIncome -14 -36 -74 -58 -52
Depreciation 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 0 2 9 10 8
AccountsReceiva 0 0 0 0 0
InventoryCS 0 0 0 0 0
AccountsPayable 0 1 5 -5 0
OtherWorkingCap -1 1 -1 1 0
OtherNonCashIte 0 4 0 0 0
NetCashProvided -15 -28 -60 -52 -44
InvestmentsInPP 0 0 -1 -1 0
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve 0 -57 -287 -137 -115
SalesMaturities 0 0 196 189 150
PurchasesOfInta 0 0 0 0 0
OtherInvestingA 0 0 0 0 0
NetCashUsedForI 0 -57 -92 51 36
DebtIssued 0 7 0 0 20
DebtRepayment 0 0 -1 -3 -4
CommonStockIssu 0 103 130 0 0
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 0 -2 1 0 0
NetCashProvided 41 108 129 -3 17
NetChangeInCash 26 23 -23 -3 8
CashAtBeginning 10 36 58 36 32
CashAtEndOfPeri 36 58 36 32 41
Retained Earnings
Year 20142015201620172018
RetainedEarning ----69-105
NetIncome ---14-36-74
StockDividend --8372149
DividendPaid -----
RetainedEarning ---69-105-180
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE -----
DeprAnnual 0----
CapitalExpendit 00001
NetPPE ----1
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0----
Amortization 0----
NewPurchases 0----
intAndGW -----
Company Profile

CEO

Jeffrey S. Hatfield

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Zafgen Inc is a biopharmaceutical company engaged in improving the health and well-being of patients affected by obesity and complex metabolic disorders. Its product candidate include Beloranib.